Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #189103 on Elite Pharmaceuticals Inc (ELTP)
Couch
03/16/16 9:35 PM
#189105 RE: John_Langston #189103
03/16/16 9:41 PM
#189106 RE: John_Langston #189103
1) Physicians call for novel abuse-deterrent opioid agonist/antagonist formulations in survey
2) MAJORITY OF PUBLIC SUPPORTS REQUIRING ABUSE DETERRENT FORMULATIONS IN MOST-ABUSED PRESCRIPTION DRUGS
3) Bowing to pressure, FDA to reform painkiller approval process